Skip to main content
Erschienen in: African Journal of Urology 1/2020

Open Access 01.12.2020 | Original Research

Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a multi-institutional comparative study

verfasst von: Amr A. Faddan, Mahmoud M. Shalaby, Mohamed Gadelmoula, Younis Alshamsi, Daniar K. Osmonov, Nasreldin Mohammed, Adel Kurkar, Atif M. Abdel Latif, Paolo Fornara, Klaus P. Jünemann

Erschienen in: African Journal of Urology | Ausgabe 1/2020

Abstract

Background

The standard surgical treatment of localized prostate cancer (PCa) has been rapidly changed along the last two decades from open to laparoscopic and finally robot-assisted techniques. Herein, we compare the three procedures for radical prostatectomy (RP), namely radical retropubic (RRP), laparoscopic (LRP), and robot-assisted laparoscopic (RALRP) regarding the perioperative clinical outcome and complication rate in four academic institutions.

Methods

A total of 394 patients underwent RP between January 2016 and December 2018 in four academic institutions; their records were reviewed. We recorded the patient age, BMI, PSA level, Gleason score and TNM stage, type of surgery, the pathological data from the surgical specimen, the perioperative complications, unplanned reoperating, and readmission rates within 3 months postoperatively. Statistical significance was set at (P < 0.05). All reported P values are two-sided.

Results

A total of 123 patients underwent RALRP, 220 patients underwent RRP, and 51 underwent LRP. There was no statistically significant difference between the three groups regarding age, BMI, prostatic volume, and preoperative PSA. However, there were statistically significant differences between them regarding the operating time (P < .0001), catheterization period (P < .001), hospital stay (P < .0001), and overall complications rate (P = .023).

Conclusions

The minimally invasive procedures (RALRP and LRP) are followed by a significantly lower complication rate. However, the patients’ factors and surgical experience likely impact perioperative outcomes and complications.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
PCa
prostate cancer
RP
radical prostatectomy
RRP
radical retropubic prostatectomy
LRP
laparoscopic radical prostatectomy
RALRP
robot-assisted laparoscopic radical prostatectomy
BMI
body mass index
PSA
prostate-specific antigen
LNDs
lymph node dissection
SSIs
surgical site infections
PSMs
positive surgical margins
MIRP
minimally invasive radical prostatectomy
UR
unplanned reoperation

1 Background

Radical prostatectomy (RP) is the surgical treatment of prostate cancer (PCa), which has been performed for more than 100 years [1]. Since its introduction in 1947 by Millin, radical retropubic approach (RRP) became the most popular and its morbidity reduced substantially after several detailed anatomic studies performed in fetal and adult cadavers in the late 1970s and the early 1980s provided critical insight into the periprostatic anatomy, especially that of the dorsal vein complex, the neurovascular bundle, and the striated urethral sphincter [2].
Fifty years later, Schuessler and colleagues in 1997 performed the first laparoscopic radical prostatectomy (LRP) that slowly rose in popularity and became a widespread minimally invasive alternative to RRP, due to its advantages, such as the lower blood loss and transfusion together with a shorter hospital stay, reduced catheterization time, better pain control and the faster return to everyday activities [3].
Claude C Abbou was the first to perform the robot-assisted laparoscopic approach (RALRP) in the year 2000 [4]. The robot offered improved visualization, increased dexterity, restored proper hand–eye coordination, and an ergonomic position for the surgeon. Despite these well-recognized benefits, it has profound drawbacks such as the cost of acquiring and maintaining this new technology can be prohibitive [5].
Despite the wide diffusion of LRP and RALRP over the past 10 years in Europe and the USA, no consensus has been attained regarding the utility of RRP, LRP, and RALRP for localized PCa [6]. Several comparative studies done and stated that LRP and RALRP are associated with decreased operative blood loss, decreased risk of transfusion, and similar risk of positive surgical margin when compared with RRP [7, 8]. Herein, we present our experience with RRP, LRP, and RALRP regarding the perioperative outcomes and complications rates.

2 Methods

A total of 394 patients underwent RP between January 2016 and December 2018 in four academic institutions; their records were reviewed. All radical prostatectomies were done for organ-confined PCa and locally advanced PCa (T3) with a life expectancy for more than 10 years. Patients underwent salvage procedure for advanced PCa (pT4), previous prostate operations, and extraperitoneal RALP are excluded.
Radical prostatectomy was done under general anesthesia, performed according to the techniques described by Walsh, 1983 either RRP, extraperitoneal LRP, or transperitoneal RALP [9]. We recorded the patient age, BMI, PSA level, Gleason score and TNM stage, type of surgery, the pathological data from the surgical specimen, the perioperative complications, unplanned reoperating, and readmission rates within 3 months postoperatively.
Operative drains were usually removed between the 3rd and the 5th postoperative day. A cystogram was performed on the 7th postoperative day to assess the integrity of vesicourethral anastomosis, and the urethral catheter was removed if no leakage appeared in the cystogram. The patients were usually discharged on the 8th postoperative day.
Statistical analysis was performed using the IBM SPSS Statistics (Version 21.0. Armonk, NY: IBM Corp). A descriptive and comparative statistical analysis of pooled data by using the Mann–Whitney U test was used to compare medians, the independent t test and one-way ANOVA were used to compare means across the groups, and the Chi-squared test and Fisher’s exact test were used for bivariate analysis. Correlations between different items in our study were done using Spearman or Pearson correlation coefficient. Multivariate analysis: logistic regression was applied for significant variables. Statistical significance was set at (P < 0.05). All reported P values are two-sided.

3 Results

A total of 123 patients underwent RALRP, 220 patients underwent RRP, and 51 underwent LRP. The patient demographic data for the three groups are compared in Table 1. The main bulk of the cases is from the second and third institutions, as the robotic surgery is not available in the first and recently added to the fourth one. According to match-pairing, there was no statistical significance between the groups regarding the age, BMI, the preoperative prostatic volume, and the preoperative PSA.
Table 1
Patients’ characteristics
 
RALP
RRP
LRP
Overall
P value
No. of cases
123
220
51
394
 
Age (yr.): Mean ± SD
67.8 ± 6.6
67.4 ± 6.8
65.6 ± 6.2
67.4 ± 6.7
.133
BMI (kg/m2): Mean ± SD
26.9 ± 3.6
27.4 ± 4.1
27.7 ± 3.5
27.3 ± 3.9
.634
BMI (%)
    
.102
 Normal (18.5–24.9)
31.3
24.7
19.6
31.5
 
 Overweight (25–29.9)
52.2
41.8
60.8
47.1
 
 Obese (30 or greater)
16.4
23.5
19.6
21.3
 
ASA score (%)
    
.024
 I
3.8
5.9
3.9
5.1
 
 II
77.5
73.5
94.1
77.6
 
 III
18.8
20.6
2
17.3
 
PSA (ng/mL): median
7.5
8.8
7.9
8.1
.204
Prostatic volume (cm3): Mean ± SD
44.1 ± 21.6
41.7 ± 20.1
44.5 ± 20.7
42.8 ± 20.7
.502
Table 2 shows the perioperative data. A statistically significant difference between the groups detected in all the operative parameters mainly the nerve-sparing technique, lymph node dissection (LNDs), the hemoglobin (Hb) and hematocrit (Hct) loss, and the operative time. The nerve-sparing procedures were more frequent in patients underwent RALRP (74%) and the lymph node dissection was more frequent in patients underwent RRP (96.4%). The catheterization time was the statistically significant difference between all groups in favor of RALRP; however, the LRP group had shorter hospitalization time which also statically significant.
Table 2
Perioperative data
 
RALP
RRP
LRP
Overall
P value
Nerve sparing (%)
74
45.5
21.6
51.3
<.0001
LNDS (%)
88.6
96.4
41.2
86.8
<.0001
Operative time (min): Mean ± SD
295.5 ± 58.5
223.7 ± 50.8
171.2 ± 61.2
239.4 ± 68.6
<.0001
Hb loss (g/dl): Mean ± SD
3.7 ± 1.7
4.2 ± 1.4
2.1 ± 0.7
3.7 ± 1.6
<.0001
Hct loss (%): Mean ± SD
10.3 ± 4.7
12.1 ± 4.4
6.8 ± 3.1
10.8 ± 4.7
<.0001
Catheter time (days): Mean ± SD
8.4 ± 4.3
10.4 ± 5.6
11.8 ± 9.4
9.9 ± 6
<.001
Hospital stay (days): Mean ± SD
9.9 ± 4
13.6 ± 9.2
11.1 ± 2.6
12 ± 7.5
<.0001
Hb hemoglobin, Hct hematocrit level, LNDs lymph node dissection
Overall, there was a statistically significant difference between all the groups regarding the postoperative pathological evaluation except the Gleason’s score. The results are summarized in Table 3. A pT2 were more frequently diagnosed in patients who underwent RALRP; however, pT3 were more in the RRP group. Patients underwent RRP had a worse oncological outcome as about 25% of them were N1 and 36.5% had positive surgical margins.
Table 3
Postoperative pathological data
 
RALP
RRP
LRP
Overall
P value
pT stage (%):
    
.011
 T2
70.7
54.3
62.7
60.6
 
 T3
29.3
45.7
37.3
39.4
 
N stage (%):
    
< .0001
 Nx
11.4
3.6
58.8
13.2
 
 N0
80.5
70.5
41.2
69.8
 
 N1
8.1
25.9
0
17
 
Gleason score (%):
    
.065
 < 6
0.8
0.9
0
0.8
 
 6
21.1
22
27.5
22.4
 
 3 + 4
25
28
41
31.9
 
 4 + 3
27
20
19.6
22.7
 
 ≥8
15.4
28.4
11.8
22.2
 
No. of lymph node removed
     
 Mean ± SD
14.8 ± 9.2
24.2 ± 11.5
12.6 ± 8.7
20.5 ± 11.7
< .0001
Margins (%)
    
.021
 Positive
22.7
36.5
25.5
30.8
 
 Negative
77.3
63.5
74.5
69.2
 
Table 4 summarizes the percentage of the incidence of postoperative complications for each group. A statistically significant difference between the groups in some specific complications; anastomotic insufficiency, surgical site infections (SSIs), and unplanned reoperation rate.
Table 4
Overall and specific complications after RPs
 
RALP
RRP
LRP
Total
P value
Total complicated cases: No. (%)
47 (38.2)
118 (53.6)
24 (47.1)
189 (48)
.023
Open conversion: No. (%)
3 (2.4)
0
2 (3.9)
5 (1.3)
< .0001
Vascular injuries: No. (%)
2 (1.6)
1 (0.5)
1 (2)
4 (1)
.450
Rectal injury: No. (%)
2 (1.6)
4 (1.8)
1 (2)
7 (1.8)
.986
Anastomotic insufficiency: No. (%)
10 (8.1)
38 (17.3)
13 (25.5)
61 (15.5)
.009
Hemorrhagic complications: No. (%)
4 (3.3)
1 (0.5)
0
5 (1.3)
.058
Postoperative urinary retention: No. (%)
0
2 (0.9)
1 (2)
3 (0.8)
.372
Lymphocele: No. (%)
10 (8.1)
25 (11.4)
1 (2)
36 (9.1)
.099
Thromboembolic complication: No. (%)
2 (1.6)
4 (1.8)
1 (2)
7 (1.8)
.986
Urinary tract infections: No. (%)
1 (0.8)
4 (1.8)
0
5 (1.3)
.499
SSIs: No. (%)
5 (4.1)
28 (12.7)
2 (3.7)
35 (8.9)
.011
Ileus: No. (%)
3 (2.4)
2 (0.9)
1 (2)
6 (1.5)
.520
Transfusion: No. (%)
7 (5.7)
11 (5)
2 (3.9)
20 (5.1)
.887
Postoperative urethral stricture: No. (%)
1 (0.8)
2 (0.9)
1 (2)
4 (1)
.768
Postoperative ureteral stricture: No. (%)
0
1 (0.5)
0
1 (0.3)
.673
Death: No. (%)
0
2 (0.9)
0
2 (0.5)
Reoperations rates: No. (%)
9 (7.3)
37 (16.8)
4 (7.8)
50 (12.7)
.022
Readmission rates with 3 months: No. (%)
6 (4.9)
12 (5.5)
2 (3.9)
20 (5.1)
.897
Our data show that the patients underwent RALRP were more likely to have nerve-sparing procedures, longer operating time, and higher intraoperative vascular injuries than others RP. However, they are less likely to have positive surgical margins (PSMs), overall complications, anastomotic insufficiency, open conversion, and unplanned reoperation.
Patients who underwent RRP were likely to have LNDs, the greater number of removed LN, about 45% of patients were T3, and 25% of patients were N1, Hb and Hct loss, PSMs, longer hospital stay, higher overall complications, unplanned reoperation, and readmission rate and SSIs.
Patients underwent LRP unlikely to have positive lymph nodes, nerve-sparing procedures and so had shorter operating time; however, they likely to have anastomotic insufficiency and longer catheter time.

4 Discussion

The minimally invasive RP has comparable cancer control outcomes of open prostatectomy, besides faster convalescence, decreased blood loss and transfusion rates, decreased postoperative pain, and shorter catheterization time [1012]. The techniques for LRP have been well developed and refined the learning curve becomes shorter than once reported [13].
Between 1962 and 2002, the average life expectancy in the German population increased from 67.1 to 75.6 years in men and from 72.7 to 81.3 years in women with an average gain of approximately 2.2 years per decade in both genders [14]. The mean age of men that underwent RP in our study was 67.4 ± 6.7 years at the time of surgery; these men generally had a life expectancy of at least 10 years.
Regarding the BMI, approximately 68% of our patients were overweight and obese, so they had an increased risk of morbidity and mortality according to the literature [15].
The available literature suggests that the duration of RP procedures decreases with surgeon experience and skill; however, the operating time is longer in RALRP compared to other RP, thus also in all publications due to docking time and learning curve and time which may reach about 60 min [16].
RALRP eases the performance of watertight urethra-vesical anastomosis allows for earlier removal of the Foley catheter. The average time until catheter removal in the RALRP series is 6 to 12 days that matches our results [17].
Hospitalization time after surgery remains one of the critical components to medical expenditures for a given surgical procedure and is considered an indicator of a quick recovery and constitutes one of the criteria that patients use to evaluate the success of the surgery. As in our study, a statistically significant difference between groups was found for the length of hospital stay in favor of RALRP.
PSMs after RP are uniformly considered an adverse outcome associated with the failure of the surgery to achieve the cure of the PCa [18]. Our data show that patients who underwent RRP were more likely to have PSMs; however, this can be attributed to the inclusion of higher stage and nodal disease in the RRP group.
The data presented in the literature showed that the perioperative parameters and the main complications rates are better in RALRP than the other types which match with our study; others reported longer hospitalization and catheterization times, and higher complication rate with RALRP [1921].
Open conversion from a minimally invasive approach to an open procedure, due to failure to progress or uncertainty of dissection planes, usually occurs during a surgeon’s early experience and not considered a complication by many [22].
The unplanned reoperation (UR) within 30 days of radical prostatectomy was 1.2%. Unplanned reoperation was significantly lower in the minimally invasive radical prostatectomy (MIRP) group (1.1% vs. 1.5%, P value 0.01). Bleeding, wound dehiscence, and acute retention were the most common indications for UR. In our study, the reoperation rate was 12.7% (Table 4); the main causes for unplanned reoperations were SSIs 42%, lymphocele 36%, bleeding complications 8%, and others 4% [23].
There are some limitations in our study such as comparing the RALRP, LRP, and RRP performed by different surgeons with variable experience. Another limitation of this current study was that it was designed to compare only the perioperative and pathological and not the functional results. As it is a retrospective review of our database, non-randomization and even selection bias might impact our study.

5 Conclusion

Our results and the published data show that RALRP and LRP are followed by a significantly lower complication rate. However, the patients’ factors, selection bias, and surgical experience likely impact perioperative outcomes and complications.

Acknowledgements

None.
The need for approval for this study was waived by the Ethics committees at Assiut, Kiel, and Martin-Luther universities and Al Qassimi Hospital, based on its retrospective nature.
Done and approved.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Literatur
1.
Zurück zum Zitat Young HH (2002) The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation, which was carried out in four cases. (Reprinted from Bull Johns Hopkins University, vol XVI, pg 315-321, 1905). J Urol 168(3):914–921CrossRef Young HH (2002) The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation, which was carried out in four cases. (Reprinted from Bull Johns Hopkins University, vol XVI, pg 315-321, 1905). J Urol 168(3):914–921CrossRef
2.
Zurück zum Zitat Campbell MF, Walsh PC, Wein AJ (2012) Campbell-Walsh Urology: Vol. 3, Chapter 100, 10th edn. Saunders Elsevier, Philadelphia, PA, pp 2771–2788 Campbell MF, Walsh PC, Wein AJ (2012) Campbell-Walsh Urology: Vol. 3, Chapter 100, 10th edn. Saunders Elsevier, Philadelphia, PA, pp 2771–2788
3.
Zurück zum Zitat Hoznek A, Menard Y, Salomon L et al (2005) Update on laparoscopic and robotic radical prostatectomy. Curr Opin Urol 15(3):173–180CrossRef Hoznek A, Menard Y, Salomon L et al (2005) Update on laparoscopic and robotic radical prostatectomy. Curr Opin Urol 15(3):173–180CrossRef
4.
Zurück zum Zitat Abbou CC, Hoznek A, Salomon L et al (2001) Laparoscopic radical prostatectomy with a remote-controlled robot. J Urol 165(6 Pt 1):1964–1966CrossRef Abbou CC, Hoznek A, Salomon L et al (2001) Laparoscopic radical prostatectomy with a remote-controlled robot. J Urol 165(6 Pt 1):1964–1966CrossRef
5.
Zurück zum Zitat Eichel L, Ahlering TE, Clayman RV (2004) Role of robotics in laparoscopic urologic surgery. Urol Clin North Am 31(4):781–792CrossRef Eichel L, Ahlering TE, Clayman RV (2004) Role of robotics in laparoscopic urologic surgery. Urol Clin North Am 31(4):781–792CrossRef
6.
Zurück zum Zitat Sridharan K, Sivaramakrishnan G (2018) Prostatectomies for localized PCa: a mixed comparison network and cumulative meta-analysis. J Robot Surg 12(4):633–639CrossRef Sridharan K, Sivaramakrishnan G (2018) Prostatectomies for localized PCa: a mixed comparison network and cumulative meta-analysis. J Robot Surg 12(4):633–639CrossRef
7.
Zurück zum Zitat Parsons JK, Bennett JL (2008) Outcomes of retropubic, laparoscopic, and robotic-assisted prostatectomy. Urology 72:412–416CrossRef Parsons JK, Bennett JL (2008) Outcomes of retropubic, laparoscopic, and robotic-assisted prostatectomy. Urology 72:412–416CrossRef
8.
Zurück zum Zitat Sugihara T, Yasunaga H, Horiguchi H et al (2014) Robot-assisted versus other types of radical prostatectomy: population-based safety and cost comparison in Japan, 2012–2013. Cancer Sci 105:1421–1426CrossRef Sugihara T, Yasunaga H, Horiguchi H et al (2014) Robot-assisted versus other types of radical prostatectomy: population-based safety and cost comparison in Japan, 2012–2013. Cancer Sci 105:1421–1426CrossRef
9.
Zurück zum Zitat Walsh PC, Lepor H, Eggleston JC (1983) Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 4(5):473–485CrossRef Walsh PC, Lepor H, Eggleston JC (1983) Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 4(5):473–485CrossRef
10.
Zurück zum Zitat Eastham JA, Scardino PT, Kattan MW (2008) Predicting an optimal outcome after radical prostatectomy: the Trifecta Nomogram. J Urol 179(6):2207–2210CrossRef Eastham JA, Scardino PT, Kattan MW (2008) Predicting an optimal outcome after radical prostatectomy: the Trifecta Nomogram. J Urol 179(6):2207–2210CrossRef
11.
Zurück zum Zitat Patel VR, Sivaraman A, Coelho RF et al (2011) A new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 59(5):702–707CrossRef Patel VR, Sivaraman A, Coelho RF et al (2011) A new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 59(5):702–707CrossRef
12.
Zurück zum Zitat Trabulsi EJ, Guillonneau B (2005) Laparoscopic radical prostatectomy. J Urol 173(4):1072–1079CrossRef Trabulsi EJ, Guillonneau B (2005) Laparoscopic radical prostatectomy. J Urol 173(4):1072–1079CrossRef
13.
Zurück zum Zitat Martina GR, Giumelli P, Scuzzarella S et al (2005) Laparoscopic extraperitoneal radical prostatectomy–learning curve of a laparoscopy-naive urologist in a community hospital. Urology 65:959–963CrossRef Martina GR, Giumelli P, Scuzzarella S et al (2005) Laparoscopic extraperitoneal radical prostatectomy–learning curve of a laparoscopy-naive urologist in a community hospital. Urology 65:959–963CrossRef
14.
Zurück zum Zitat Klenk J, Rapp K, Büchele G et al (2007) Increasing life expectancy in Germany: quantitative contributions from changes in age- and disease-specific mortality. Eur J Public Health 17(6):587–592CrossRef Klenk J, Rapp K, Büchele G et al (2007) Increasing life expectancy in Germany: quantitative contributions from changes in age- and disease-specific mortality. Eur J Public Health 17(6):587–592CrossRef
15.
Zurück zum Zitat Calle EE, Rodriguez C, Walker-Thurmond K et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638CrossRef Calle EE, Rodriguez C, Walker-Thurmond K et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638CrossRef
16.
Zurück zum Zitat Alenizi AM, Valdivieso R, Rajih E et al (2015) Factors predicting prolonged operative time for individual surgical steps of robot-assisted radical prostatectomy (RARP): a single surgeon’s experience. Can Urol Assoc J 9(7–8):E417–E422CrossRef Alenizi AM, Valdivieso R, Rajih E et al (2015) Factors predicting prolonged operative time for individual surgical steps of robot-assisted radical prostatectomy (RARP): a single surgeon’s experience. Can Urol Assoc J 9(7–8):E417–E422CrossRef
17.
Zurück zum Zitat Novara G, Ficarra V, Rosen RC et al (2012) Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol 62(3):431–452CrossRef Novara G, Ficarra V, Rosen RC et al (2012) Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol 62(3):431–452CrossRef
18.
Zurück zum Zitat Yossepowitch O, Briganti A, Eastham JA et al (2014) Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65(2):303–313CrossRef Yossepowitch O, Briganti A, Eastham JA et al (2014) Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65(2):303–313CrossRef
19.
Zurück zum Zitat Dindo D, Clavien P (2008) What is a surgical complication? World J Surg 32(6):939–941CrossRef Dindo D, Clavien P (2008) What is a surgical complication? World J Surg 32(6):939–941CrossRef
20.
Zurück zum Zitat Rozet F, Jaffe J, Braud G et al (2007) A direct comparison of robotic-assisted versus pure laparoscopic radical prostatectomy: a single-institution experience. J Urol 178(2):478–482CrossRef Rozet F, Jaffe J, Braud G et al (2007) A direct comparison of robotic-assisted versus pure laparoscopic radical prostatectomy: a single-institution experience. J Urol 178(2):478–482CrossRef
21.
Zurück zum Zitat Ficarra V, Novara G, Artibani W et al (2009) Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 55(5):1037–1063CrossRef Ficarra V, Novara G, Artibani W et al (2009) Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 55(5):1037–1063CrossRef
22.
Zurück zum Zitat Bhayani SB, Pavlovich CP, Strup SE et al (2004) Laparoscopic radical prostatectomy: a multi-institutional study of conversion to open surgery. Urology 63(1):99–102CrossRef Bhayani SB, Pavlovich CP, Strup SE et al (2004) Laparoscopic radical prostatectomy: a multi-institutional study of conversion to open surgery. Urology 63(1):99–102CrossRef
23.
Zurück zum Zitat Sarhan A, Shabsigh A (2015) The impact of surgical technique on unplanned reoperation after open and minimally invasive radical prostatectomy: analysis of the NSQIP database. J Am College Surg 221(4, Supplement 1):S174CrossRef Sarhan A, Shabsigh A (2015) The impact of surgical technique on unplanned reoperation after open and minimally invasive radical prostatectomy: analysis of the NSQIP database. J Am College Surg 221(4, Supplement 1):S174CrossRef
Metadaten
Titel
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a multi-institutional comparative study
verfasst von
Amr A. Faddan
Mahmoud M. Shalaby
Mohamed Gadelmoula
Younis Alshamsi
Daniar K. Osmonov
Nasreldin Mohammed
Adel Kurkar
Atif M. Abdel Latif
Paolo Fornara
Klaus P. Jünemann
Publikationsdatum
01.12.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
African Journal of Urology / Ausgabe 1/2020
Print ISSN: 1110-5704
Elektronische ISSN: 1961-9987
DOI
https://doi.org/10.1186/s12301-020-00083-0

Weitere Artikel der Ausgabe 1/2020

African Journal of Urology 1/2020 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.